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Abstract: The purpose of the present study was to evaluate the use of salivary Chromogranin-A 
(CgA), which is already used in general as a mental stress marker, for studying the stressful 
situation created by simulated monotonous driving. After informed consent 25 healthy male & 
female subjects were studied, under constant environment-controlled conditions. We measured the 
following physiological variables: blood pressure (BP), cardiac output (CO), total peripheral 
resistance (TPR), normalized pulse volume (NPV) as an index of alpha-adrenergic sympathetic 
activity to the finger arteriolar vessels, levels of cortisol and CgA during monotonous driving. The 
induced stress led to the expected decreases in NPV and increases in TPR and BP caused by 
peripherally-related sympathetic acceleration. However, CgA levels were found to fall gradually in 
accordance with the gradual increase of subjective rating of stress (SRS) and significantly 
(p<0.01) decreased over the period of the simulated monotonous driving.  
Our hypothesis for the gradual decrease of CgA levels during the simulated monotonous driving 
is as follows. CgA, catestatin and Catecholamines are co-released into the extra-cellular 
environment. Peripheral sympathetic activity was accelerated by stress resulting from the 
simulated monotonous driving. Upon peripheral vessel constriction, an increase in total peripheral 
resistance (TPR) then increased BP which, in turn, activated catestatin. Consequently, secretion of 
CgA was blocked by the co-secreted catestatin from chromaffin granules. The results obtained 
strongly indicate that, although CgA has been reported as a possible marker of stress, CgA levels 
are not increased in the stressful situation of simulated monotonous driving. 
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CgA : Chromogranin-A 
BP : blood pressure  
CO : cardiac output  
TPR : total peripheral resistance  
NPV : normalized pulse volume  
SRS : subjective rating of stress 
 
 




There are many stressors in our modern day society which can threaten our health and life. 
The automobile is regarded in most societies as an essential commodity, however there have 
been considerable increases in traffic accidents every year in most industrialized nations. 
According to the WHO, traffic accidents cause two deaths every minute and 1.5 injuries every 
second [1]. Drivers may frequently be faced with too many driving stresses, such as right or 
left turns at busy intersections, traveling at too high a speed, or combinations of tasks 
requiring decisions and actions. Surprisingly, stress can also occur when drivers are trying to 
shake off their drowsiness in situations when they are under considerably less pressure to 
make decisions despite needing to perform ongoing monotonous driving tasks [2]. Decreased 
vigilance and fatigue are major factors accounting for driver error when under this form of 
increased stress [3, 4], and these are among the most common causes of traffic accidents. In 
order to understand these complex issues, and thereby hopefully reduce the number of traffic 
accidents, it is important to perform objective measurements of physiological phenomena 
thought to be associated with driver stress. Such measurements should include hormones and 
physiological signals in subjects whilst they are performing driving tasks.  
Possible biochemical implications of stress have been evaluated by measuring cortisol and 
catecholamine as a neuroendocrine stress markers [5, 6]. However, the measurement of these 
hormones for this purpose has several limitations, such as the need for the invasive sampling 
of blood, although cortisol can be measured in saliva, and the fact that cortisol takes 20-30 
mins to be secreted after stress [7] and is also influenced by circadian rhythm [8, 9]. The 
levels reached a peak value at 1 hour after awakening, then decreased gradually during the 
day. Nevertheless, since hormone levels in saliva are known to reflect well the levels in 
plasma, measurement of salivary stress hormones offers the prospect of a very convenient and 
useful approach for research into stress. Examples of possible salivary secreted hormones are 
immunoglobulin-A (sIgA) [10, 11], salivary amylase [12], and salivary Chromogranin-A 
(CgA) [13]. Salivary CgA was recently reported to be a useful biochemical marker of stress. 
The major advantage of the use of salivary CgA is, therefore, that its sampling is non-invasive 
and it can be performed in non-stressful conditions. Furthermore it is secreted immediately 
after stress [14] without the influence of circadian rhythm [9]. 
CgA, a 48-kDa acidic polypeptide, is the major soluble protein in the core of catecholamine 
(CA) storage vesicles. This protein is believed to play an intracellular role as a key regulator 
of secretory granule biogenesis and an extracellular function as a precursor of several 
regulatory peptides for the endocrine and nuroendocrine cells. CgA is also a pro-hormone, 
subject to proteolytic cleavage during and after secretion, yielding several biologically active 
peptides such as pancreastatin, vasostatin, prochromacin, chromacin, and catestatin. 
Pancreastatin inhibits glucose stimulated insulin release from pancreatic islet β-cells and 
parathyroid hormone release from chief cells, and vasostatin relaxes vascular smooth muscle 
and inhibits parathyroid hormone release. The novel fragment of CgA termed catestatin is a 
potent inhibitor of CA release, acting as a non-competitive antagonist on the nicotinic 
cholinergic receptor. CgA, catestatin and CA are co-released into the extra-cellular 
environment [15]. CA mediates sympathoadrenal activity on cardiovascular target cells to 
increase blood pressure. The release of CA is then subsequently blocked by the co-secreted 
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catestatin from chromaffin granules [16-19]. 
The purpose of the present study was to evaluate the use of salivary CgA, which is already 
used in general as a mental stress marker, in response to the stressful situation created by 
simulated monotonous driving. Under laboratory conditions, in healthy subjects during 
simulated monotonous driving, we have measured physiological variables together with 
salivary CgA levels. 
2. MATERIALS AND METHOD 
A. Experimental Setup 
Fig. 1 shows a schematic diagram of our experimental system. This can measure 
physiological signals such as blood pressure (BP), cardiac output (CO), total peripheral 
resistance (TPR), normalized pulse volume (NPV) and levels of CgA during simulated 
monotonous driving. Saliva samples were collected every 10 minutes (Fig.1-(a)) and levels of 
CgA and cortisol were immediately measured, using enzyme linked immunosorbent assay 
(ELISA), by Yanaihara Institute Inc. The BP & CO monitoring systems were developed as 
experimental instruments and have been described fully elsewhere [20-22]. The BP system, 
utilizing the volume-compensation principle, is capable of measuring instantaneous BP in the 
finger (Fig.1-(b)), and the admittance cardiograph provides an instantaneous indication of CO 
(Fig.1-(c)). The finger photo-plethysmograph (FPG) (MPN1001, Medisens Co. Ltd., Japan) 
consists of a near-infrared light source and a photosensor which were placed on opposite sides 
of the distal part of the basal phalanx of the left middle finger (Fig.1-(d)). Normalized pulse 
volume (NPV) was obtained from the DC and AC (pulsatile) components of the FPG signal. 
This measure has been proposed as a useful index of α-adrenergic sympathetic activity in the 
finger arteriolar vessels [23].  
The main part of the experimental system comprises of a video projector (LV-5210, Canon 
Co., Ltd., Japan) and an 80-inch screen for displaying an image to the subject, a driver’s seat 
and car steering wheel, two CCD cameras to monitor the subject, and two conventional PCs. 
To conduct the experiment the subject was asked to sit down quietly on the driver’s seat with 
their left hand held horizontally on an armrest at heart level and to operate a car simulator 
steering wheel with their right-hand. All of the output signals from these devices were stored 
in one of the two desktop PCs via a 16-bit A/D converter with 1-ms sampling interval for the 
purpose of real-time display using LabVIEW 7 Express (National Instruments Co., Ltd., 
USA). 
B. Measurement Quantities 
We acquired the following data during the experiment: beat-by-beat systolic (SBP), mean 
(MBP) and diastolic blood pressure (DBP) in the subject’s left forefinger at the proximal 
phalanx; beat-by-beat cardiac output (CO) with the RR interval of the ECG (RR); beat-by-
beat total peripheral resistance (TPR (=MBP/CO)); beat-by-beat normalized pulse volume 
(NPV) as an indication of local peripheral resistance; and levels of salivary CgA and cortisol. 
In this experiment the level of stress as estimated from the answers given in a questionnaire 
every 10-min, was used as a reference, termed the “Subjective rating of stress” (SRS). 
Although the sensation of stress is difficult to report, because it is purely subjective, we used 
the reporting by the subject of their perceived stress on a 9-level scale by selecting any 
number between Level-1 (not stressful at all) and Level-9 (extremely stressful); this is 
referred to as Kakizaki’s method [24]. 
C. Subjects & Procedures 
After giving informed consent 25 healthy male & female subjects [26.8±8.0 SD yrs] 
without known cardiovascular disorders participated in the present preliminary experiment. 
The subjects were asked to maintain their regular daily routines and sleeping/waking hours 
from at least 2 days before the experiment took place. They were studied in a temperature-
controlled quiet room held at 25 °C, the study beginning at 9:00 am. The subjects were 
requested to sit down on the driver’s seat where they could drive on a simulated oval test-
3 
course. After resting for 10-min (baseline session) the subjects drove for a maximum of 120-
min (simulated driving session). The session was terminated earlier than the 120-min 
maximum if the simulated vehicle was deemed to have moved out of the specified lane. After 
the simulated driving session the subject rested for 5-min (end session). In order to simulate a 
real monotonous driving situation, each subject was previously informed that they had to 
continue driving safely as though they were actually driving, and that they should maintain a 
speed of 80~120 km/h, and to drive within a specified lane. Saliva was collected every 10 
minutes during experiment. 
3. RESULTS 
Fig. 2 shows an example of 135-min trend-charts of physiological variables together with 
those of CgA level and reference of stress level (subjective rating of stress : SRS) obtained in 
one subject. As shown on the graph, NPV, as a possible marker of the peripheral sympathetic 
activity, indicates that vasomotor constriction gradually accelerates during the simulated 
driving session as compared to that in the baseline session. RR and CO are essentially 
constant. TPR clearly demonstrates that the vascular resistance is gradually increased. BP 
gradually increases during the driving session. The levels of CgA and cortisol were found to 
fall gradually as the SRS gradually increased. Salivary cortisol has generally been used as a 
biological maker of stress and, to compare this with CgA levels, measurements using enzyme 
linked immunosorbent assay (ELISA) from just 3 subjects in this present experiment were 
used. 
We found that monotonous driving stress led to the expected decreases in NPV and 
increases in TPR and BP due to peripherally-related sympathetic acceleration. This finding 
has already been demonstrated in our earlier work [25]. It could be inferred from these results 
that the driver felt considerably stressed during the simulated driving.  
Fig. 3 shows the time course of the means±SDs (n=25) of the percentage change of the 
CgA level, MBP, RR, CO, TPR and NPV reactions in the simulated driving session period as 
compared to the baseline session. The right-hand panel indicates the means±SDs of the 
average values of the change of the physiological measurements during whole driving 
sessions with respect to the baseline values obtained for all subjects. Also, the asterisks 
indicate the level of statistical significance for the changes, according to the Wilcoxon test 
(*p<0.05, **p<0.01). Since the duration of the simulated driving session was different for 
each subject, the horizontal axis is normalized and shown as the %-age of each driving 
session period (%-time of driving session). 
As is seen in Fig 3 it is clearly demonstrated that the MBP gradually increases and NPV 
decreases during the driving session, and these changes are statistically significant (p<0.01). 
These results were caused by constrictive peripheral vasomotor regulation. Furthermore, CgA 
levels were statistically significantly decreased (p<0.01) over the period of the simulated 
monotonous driving. These findings lead us to suggest that CgA levels are not increased in a 
stress-induced monotonous driving situation. 
4. DISCUSSION 
The study described here attempted to investigate the possible use of changes in salivary 
Chromogranin-A (CgA) levels that occur during simulated monotonous driving for assessing 
an automobile driver’s stress levels which, in turn, is hypothesized to reflect their 
physiological potential to drive safely. In fact, there appears to be an optimal level of stress 
educing high performance during driving; this may be described by The Yerkes-Dodson law, 
which is an empirical relationship between performance and stress [26]. In order for a driver 
to be able to control their vehicle safely, making appropriate decisions when confronted with 
demanding or hazardous circumstances, and remaining vigilant during monotonous driving, it 
is generally agreed that they need to be alert. The purpose of our work, and that of others, is to 
develop some kind of in-car technology, based on the measurement of physiological status, to 
help ensure a driver is appropriately alert. In order to realize such a system in the future, it is 
important to investigate thoroughly the physiological reactions, including neuroendocrine 
markers, during driving. 
CgA is a glycoprotein stored in the dense core granules of the adrenal medulla and of many 
4 
neuroendocrine cells and neurons. This protein is believed to play an intracellular role as a 
key regulator of secretory granule biogenesis and an extracellular function as a precursor of 
several regulatory peptides for the endocrine, cardiovascular, and nervous systems [27-31]. In 
the cytoplasm, CA is synthesized and transported into the dense core secretory granules 
(DSG). CA then binds CgA for storage in the core of the granules. Upon stimulation by 
acetylcholine (Ach), nicotinic cholinergic receptor permitting influx of Na+, which 
depolarizes the cell membrane, permitting influx of Ca2+ though voltage gated calcium 
channels. CgA is an acidic protein co-released with catecholamines (CA) and catestatin 
during exocytosis from chromaffin cells. Secreted CA triggers cardiovascular target cells to 
augment blood flow. A novel fragment of CgA, known as catestatin, inhibits CA release from 
chromaffin cells and noradrenergic neurons by acting as a non-competitive nicotinic 
cholinergic antagonist, and may therefore constitute an endogenous autocrine feedback 
regulator of sympathoadrenal activity (Fig. 4). When BP is increased by CA, the catestatin 
fragment of CgA inhibits CA and CgA release [32-35]. 
Fig. 5 shows a schematic drawing of a circulation regulatory model proposed by Deboer et 
al. [36] and a secretion regulatory mechanism of CgA. BP is feedback-controlled by the heart 
and/or the peripheral vessels through the reciprocal action of sympathetic activity and vagal 
activity so as to maintain the BP at a desired level. In this model, the heart and peripheral 
vessels modify cardiac output (CO) and total peripheral resistance of the whole body (TPR), 
respectively. The controlled BP is therefore calculated as “BP=CO*TPR”. BP is detected by 
the baroreceptor pressure sensor. Catestatin acts to enhance baroreceptor activity, increasing 
vagal tone whilst decreasing sympathetic activity [37]. As a nicotinic cholinergic antagonist, 
the best documented effect of catestatin is to inhibit catecholamine release. Catecholamines 
have important central effects to influence efferent vagal and sympathetic outflow. Catestatin 
may play a protective role against the future development of hypertension [37]. 
In this study, peripherally-related sympathetic activity, vasomotor constriction, was 
accelerated by stress stimulation during the simulated monotonous driving. Upon peripheral 
vessel constriction, an increase (p<0.01) in total peripheral resistance (TPR) as well as a 
decrease (p<0.01) in NPV then increased BP (p<0.01) in correspondence with the increase 
(p<0.01) of subjective rating of stress (SRS). These results imply that, despite being in 
monotonous situations, drivers must still face demands, such as ‘keeping an eye on 
surroundings’, ‘performing on-going monotonous tasks under constrained situations’, 
‘shaking off their drowsiness’ and so on. The results obtained here strongly indicate that long 
hours of driving under such monotonous situations can actually make a driver considerably 
stressful, resulting in a gradual rise in BP caused by an increase in vasoconstriction through 
acceleration of sympathetic activity. Furthermore, the results also indicate that the rise in BP 
during monotonous driving would be influenced by a regulation of peripheral 
vasoconstriction, TPR, rather than by cardiac function, CO. Thus, sympathoadrenal activity, 
acting mainly on the heart through circulatory blood, is not activated in this monotonous 
situation. It is known that catestatin is associated with augmented baroreflex sensitivity [37], 
wherein activation of catestatin is caused by the increase of BP, and secretion of CgA is 
blocked by the co-secreted catestatin from chromaffin granules. This would explain why in 
our study CgA levels gradually decreased during the simulated monotonous driving, despite 
CgA having been reported as a possible marker of stress. Although we have not measured 
Catecholamine levels in this experiment, because this requires invasive blood sampling, it 
seems likely that they might also be decreased in the monotonous driving situation. 
5. CONCLUSIONS  
In healthy volunteers during simulated monotonous driving, we have successfully measured 
physiological variables together with salivary CgA levels. The level of stress, as indicated by 
the subjective rating of stress and other physiological stress markers, was significantly 
increased, but the CgA level gradually decreased over the period of the simulated monotonous 
driving. The results obtained strongly indicate that, although CgA has been reported as a 
possible marker of stress, CgA levels are not increased in the stressful situation of simulated 
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Fig. 1 Schematic of experimental setup for physiological measurement during simulated 
monotonous driving. See text for explanation. 
Fig. 2 Example of 135-min trend-charts of physiological variables (BP: blood pressure, CO: 
cardiac output, TPR: total peripheral resistance, NPV: normalized pulse volume) together with 
those of CgA and cortisol level, and reference of stress level (SRS: subjective rating of stress) 
obtained in one subject. 
Fig. 3 Means±SDs of time course percent changes from baseline session during simulated 
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monotonous driving. The right-hand panel shows the means±SDs of the average values of the 
physiological measurements during the whole simulated driving session as a percentage change 
from the baseline obtained in all subjects. Asterisks indicate the statistical significance of the 
change according to the Wilcoxon test (*p<0.05, **p<0.01). See text for details. 
Fig. 4 Model for the action of catestatin on CgA secretion from chromaffin cell. Upon stimulation 
by acetylcholine (Ach), nicotinic cholinergic receptor permitting influx of Na+, which depolarizes 
the cell membrane, permitting influx of Ca2+ through voltage gated calcium channels. CgA is an 
acidic protein co-released with catecholamines (CA) and catestatin during exocytosis from 
chromaffin cells. Consequently, secretion of CgA was blocked by the co-secreted catestatin from 
chromaffin granules. 
Fig. 5 Schematic of circulation regulatory model and secretion regulatory mechanism of CgA. (a): 
Sympathetic activity and vasomotor constriction were accelerated by stimulated monotonous 
driving stress. Upon peripheral vessel constriction, an increase in TPR then increased BP. (b): 
Activation of catestatin was caused by the increase of BP. Catestatin inhibits CgA release from 
chromaffin cell by acting as non-competitive nicotinic cholinergic antagonist. 
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Fig. 1.  Schematic of experimental setup for physiological measurement during simulated monotonous driving. 
See text for explanation. 
  
 
Fig. 2. Example of 135-min trend-charts of physiological variables (BP: blood pressure, CO: cardiac output, TPR: 
total peripheral resistance, NPV: normalized pulse volume) together with those of CgA and cortisol level, and 
reference of stress level (SRS: subjective rating of stress) obtained in one subject. 
  
 
Fig. 3 Means±SDs of time course percent changes from baseline session during simulated monotonous driving. 
Right bar indicate means±SDs of average value of physiological measurement during whole simulated driving 
session from baseline obtained in all subjects. Asterisks indicate significant deviation according to the Wilcoxon 
test (*p<0.05, **p<0.01). See text for details. 
  
Fig. 4.  Model for the action of catestatin on CgA secretion from chromaffin cell. Upon stimulation by 
acetylcholine (Ach), nicotinic cholinergic receptor permitting influx of Na+, which depolarizes the cell membrane, 
permitting influx of Ca2+ though voltage gated calcium channels. CgA is an acidic protein co-released with 
catecholamines (CA) and catestatin during exocytosis from chromaffin cells. Consequently, secretion of CgA was 




Fig. 5.  Schematic of circulation regulatory model and secretion regulatory mechanism of CgA. (a): Sympathetic 
activity and vasomotor constriction were accelerated by stimulated monotonous driving stress. Upon peripheral 
vessel constriction, an increase in TPR then increased BP. (b): Activation of catestatin was caused by the increase 
of BP. Catestatin inhibits CgA release from chromaffin cell by acting as non-competitive nicotinic cholinergic 
antagonist. 
